Six years ago Abiraterone was hailed as a medical breakthrough that could offer men extra time with loved ones and a chance to delay chemotherapy and its debilitating side effects.
Today the body that recommends what can and cannot be paid for said it 'wasn't cost effective'.
Prostate cancer patients have now been told that the life-extending drug will not be routinely prescribed unless they have chemotherapy.
One man from North Yorkshire who is fighting prostate cancer is calling for a rethink:
More top news
The children on board were from Easingwold School and were travelling along roads affected by heavy rain and flooding after Christmas.
The Leeds boxer will find out tonight if she has won the coveted Sunday Times Sportswoman of the Year award.
The walls had been closed to the public at the weekend amid fears of a collapse.